Intraperitoneal engineered Newcastle disease virus encoding interleukin-12 in combination with PD-1 blockade for therapy of ovarian cancer

Activity: Talk or presentation › Oral presentation

Period	May 2023
Held at	OncLive Fellows Forum Annual Meeting (Podium Plenary)